Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD
0.01 (0.29%)
May 20, 2022 4:00 PM EDT - Market closed

Total Valuation

ABOS has a market cap or net worth of $140.94 million. The enterprise value is -$47.94 million.

Market Cap140.94M
Enterprise Value-47.94M

Important Dates

The next earnings date is Monday, June 27, 2022, before market open.

Estimated Earnings DateJun 27, 2022
Ex-Dividend Daten/a

Share Statistics

ABOS has 40.50 million shares outstanding. The number of shares has increased by 9,556.63% in one year.

Shares Outstanding40.50M
Shares Change (YoY)+9,556.63%
Shares Change (QoQ)+101.79%
Owned by Insiders (%)15.73%
Owned by Institutions (%)77.93%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio0.65
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 48.81, with a Debt / Equity ratio of 0.00.

Current Ratio48.81
Quick Ratio48.04
Debt / Equity0.00
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -58.20%, which is considered low. The company has a ROIC of -107.50%.

Return on Equity (ROE)-58.20%
Return on Assets (ROA)-43.60%
Return on Capital (ROIC)-107.50%
Revenue Per Employeen/a
Profits Per Employee-$5.91M
Employee Count14
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-78.25%
50-Day Moving Average3.78
200-Day Moving Average6.13
Average Volume (30 Days)232,119

Short Selling Information

The latest short interest is 1.90 million, so 4.68% of the outstanding shares have been sold short.

Short Interest1.90M
Short % of Shares Out4.68%
Short % of Float13.36%
Short Ratio (days to cover)9.26

Income Statement

Gross Profitn/a
Operating Income-25.00M
Net Income-82.74M
Earnings Per Share (EPS)-$2.75
Full Income Statement

Balance Sheet

The company has $189.09 million in cash and $201,000 in debt, giving a net cash position of $188.89 million or $4.66 per share.

Cash & Cash Equivalents189.09M
Total Debt201,000
Net Cash188.89M
Net Cash Per Share$4.66
Book Value216.09M
Book Value Per Share5.34
Working Capital188.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.89 million and capital expenditures -$43,000, giving a free cash flow of -$23.93 million.

Operating Cash Flow-23.89M
Capital Expenditures-43,000
Free Cash Flow-23.93M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-58.70%
FCF Yield-16.98%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yield-9,556.63%
Shareholder Yield-9,556.63%
Dividend Details

Analyst Forecast

The average price target for ABOS is $17.85, which is 412.93% higher than the current price. The consensus rating is "Buy".

Price Target$17.85
Price Target Difference412.93%
Analyst ConsensusBuy
Analyst Count10
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a